Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A24012 | 23303639 | Biofactors | Curcumin and liver disease. | 2013 | Details |
| A24013 | 23302015 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study. | 2013 | Details |
| A24014 | 23301938 | J Gastroenterol Hepatol | Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis. | 2013 | Details |
| A24015 | 23300535 | PLoS One | Systematic analysis of the gene expression in the livers of nonalcoholic steatohepatitis: implications on potential biomarkers and molecular pathological mechanism. | 2012 | Details |
| A24016 | 23300059 | Hepatology | Hedgehog pathway and pediatric nonalcoholic fatty liver disease. | 2013 | Details |
| A24017 | 23299992 | Hepatology | Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. | 2013 | Details |
| A24018 | 23299969 | Hepatology | Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis. | 2013 | Details |
| A24019 | 23299577 | Hepatology | Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models. | 2013 | Details |
| A24020 | 23298957 | Curr Opin Lipidol | Perspective: nonalcoholic fatty liver disease and cardiovascular risk. | 2013 | Details |
| A24022 | 23298439 | Ann Epidemiol | Association between history of abortion and nonalcoholic fatty liver disease in middle-aged and elderly Chinese women. | 2013 | Details |
| A24023 | 23296703 | J Immunol | Tim-3/galectin-9 regulate the homeostasis of hepatic NKT cells in a murine model of nonalcoholic fatty liver disease. | 2013 | Details |
| A24025 | 23295058 | Liver Int | Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats. | 2013 | Details |
| A24026 | 23295007 | Psychosomatics | Association of chronic liver disease with depression: a population-based study. | 2013 | Details |
| A24027 | 23294957 | Chirurgia (Bucur) | Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery. | 2013 | Details |
| A24028 | 23294935 | BMC Gastroenterol | Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population. | 2013 | Details |
| A24029 | 23294790 | J Diabetes Sci Technol | A simple Indian diabetes risk score could help identify nondiabetic individuals at high risk of non-alcoholic fatty liver disease (CURES-117). | 2012 | Details |
| A24030 | 23294411 | Hepatol Res | Transient elastography for monitoring the fibrosis of non-alcoholic fatty liver disease for 4 years. | 2013 | Details |
| A24031 | 23293873 | Aliment Pharmacol Ther | Regional anthropometric measures associated with the severity of liver injury in patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A24032 | 23293330 | J Clin Endocrinol Metab | Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. | 2013 | Details |
| A24033 | 23293250 | BMJ Open | Independent association between low serum amylase and non-alcoholic fatty liver disease in asymptomatic adults: a cross-sectional observational study. | 2013 | Details |
| A24034 | 23293232 | Georgian Med News | [Relationship gene polymorphism adipor1 with cardiovascular risk in patients with nonalcoholic fatty liver disease]. | 2012 | Details |
| A24036 | 23293202 | Ann Hepatol | Therapeutic effects of granulocyte-colony stimulating factor on non-alcoholic hepatic steatosis in the rat. | 2013 | Details |
| A24037 | 23293196 | Ann Hepatol | Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study. | 2013 | Details |
| A24038 | 23292294 | Clin Exp Med | Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease. | 2013 | Details |
| A24039 | 23289518 | Eur J Clin Invest | Iron homeostasis in the metabolic syndrome. | 2013 | Details |
| A24040 | 23289274 | Srp Arh Celok Lek | Nonalcoholic fatty liver disease and familial Mediterranean fever: are they related? | 2013 | Details |
| A24041 | 23287814 | Diabetes Res Clin Pract | Upregulation of miR-15b in NAFLD models and in the serum of patients with fatty liver disease. | 2012 | Details |
| A24042 | 23287807 | J Pediatr Gastroenterol Nutr | Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease. | 2013 | Details |
| A24043 | 23286927 | Nutr Clin Pract | Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment. | 2013 | Details |
| A24044 | 23286209 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups. | 2013 | Details |
| A24045 | 23285761 | Klin Med (Mosk) | [The prevalence of liver and gallbladder pathologies in overweight and obese patients]. | 2012 | Details |
| A24046 | 23285030 | PLoS One | Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice. | 2012 | Details |
| A24047 | 23283181 | Curr Opin Gastroenterol | Dietary treatment of nonalcoholic steatohepatitis. | 2013 | Details |
| A24048 | 23282702 | Rev Med Chil | [Association of metabolic syndrome markers with abnormal alanine aminotransferase levels in healthy children]. | 2012 | Details |
| A24049 | 23280158 | Dig Liver Dis | Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies. | 2012 | Details |
| A24050 | 23278404 | J Gastroenterol Hepatol | Impact of leptin receptor gene variants on risk of non-alcoholic fatty liver disease and its interaction with adiponutrin gene. | 2013 | Details |
| A24051 | 23278318 | Diabet Med | Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population. | 2013 | Details |
| A24052 | 23278163 | Aliment Pharmacol Ther | Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods. | 2012 | Details |
| A24053 | 23276918 | Front Biosci (Landmark Ed) | Potential applications of miRNAs as diagnostic and prognostic markers in liver cancer. | 2013 | Details |
| A24054 | 23275099 | World J Pediatr | Liver steatosis in Polish children assessed by medicolegal autopsies. | 2012 | Details |
| A24055 | 23274901 | Diabetes | Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism. | 2012 | Details |
| A24056 | 23273500 | Clin Res Hepatol Gastroenterol | Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD). | 2012 | Details |
| A24057 | 23272512 | Rev Med Chir Soc Med Nat Iasi | Non-alcoholic fatty liver disease is associated with cardiovascular risk factors of metabolic syndrome. | 2013 | Details |
| A24058 | 31528500 | J Carcinog Mutagen | Exocycilic DNA Adducts in a Murine Model of Non-alcoholic Steatohepatitis. | 2013 | Details |
| A24059 | 25702427 | Klin Med (Mosk) | [Proinflammatory cytokine levels depending on the stage of hepatic fibrosis in patients with metabolic syndrome and non-alcoholic fatty liver disease]. | 2013 | Details |
| A24060 | 25674420 | Springerplus | (-)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitis. | 2013 | Details |
| A24061 | 24959557 | ISRN Radiol | Usefulness of the bolus-tracking baseline scan for the diagnosis of hepatic steatosis in abdominal computed tomography: a feasibility study. | 2013 | Details |
| A24062 | 24933975 | Eksp Klin Gastroenterol | [Efficiency of ursodeoxycholic acid therapy in non-alcoholic fatty liver disease associated with metabolic syndrome]. | 2013 | Details |
| A24063 | 24834280 | Gastroenterol Hepatol Bed Bench | The effect of an aerobic exercise on serum level of liver enzymes and liver echogenicity in patients with non alcoholic fatty liver disease. | 2013 | Details |
| A24064 | 24772867 | Eksp Klin Gastroenterol | [Non-invasive techniques in diagnosis of steatosis and fibrosis in nonalcoholic fatty liver disease]. | 2013 | Details |
| A24065 | 24688728 | Comput Struct Biotechnol J | The Role of INDY in Metabolic Regulation. | 2013 | Details |
| A24066 | 24648896 | Biomed Rep | Quercetin improves insulin resistance and hepatic lipid accumulation in vitro in a NAFLD cell model. | 2012 | Details |
| A24067 | 24648894 | Biomed Rep | Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2012 | Details |
| A24068 | 23269818 | Am J Clin Nutr | A common variant in the peroxisome proliferator-activated receptor-γ coactivator-1α gene is associated with nonalcoholic fatty liver disease in obese children. | 2012 | Details |
| A24069 | 23268961 | Biomed Res | Protective effects of the herbal medicine goshajinkigan in a rat model of non-alcoholic fatty liver disease. | 2012 | Details |
| A24070 | 23268566 | Scand J Gastroenterol | The role of Kupffer cells in the morphogenesis of nonalcoholic steatohepatitis - ultrastructural findings. The first report in pediatric patients. | 2012 | Details |
| A24071 | 23267803 | Transplant Proc | A case report of massive vaginal variceal hemorrhage in a patient with cirrhosis secondary to nonalcoholic steatohepatitis unresolved even after successful liver transplantation. | 2012 | Details |
| A24072 | 23266468 | Diabetes Metab | Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside. | 2012 | Details |
| A24074 | 23262638 | Toxicol Pathol | Toxicant-associated steatohepatitis. | 2012 | Details |
| A24076 | 23260104 | J Pediatr | Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease. | 2012 | Details |
| A24078 | 23258548 | Mol Pharmacol | 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model. | 2012 | Details |
| A24079 | 23258240 | Recenti Prog Med | [Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin-resistance and inflammation]. | 2012 | Details |
| A24080 | 23256442 | J Med Food | Dandelion leaf extract protects against liver injury induced by methionine- and choline-deficient diet in mice. | 2012 | Details |
| A24085 | 23239917 | World J Gastroenterol | Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease? | 2012 | Details |
| A24086 | 23238855 | Endocr Rev | Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo. | 2012 | Details |
| A24087 | 23238106 | J Hepatol | A 360-degree overview of paediatric NAFLD: recent insights. | 2012 | Details |
| A24088 | 23237488 | ACS Chem Biol | A liver-selective LXR inverse agonist that suppresses hepatic steatosis. | 2012 | Details |
| A24090 | 23236362 | PLoS One | Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists. | 2012 | Details |
| A24091 | 23236229 | World J Gastroenterol | Way back for fructose and liver metabolism: bench side to molecular insights. | 2012 | Details |
| A24092 | 23236228 | World J Gastroenterol | Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease. | 2012 | Details |
| A24093 | 23234816 | Hepatogastroenterology | Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial. | 2012 | Details |
| A24094 | 23234151 | Zhongguo Zhong Yao Za Zhi | [Clinical study on prevention efficacy of Jianpi Huatan Fang in treating non-alcoholic fatty liver disease in children]. | 2012 | Details |
| A24095 | 23233555 | Hematology Am Soc Hematol Educ Program | Gaucher disease and other storage disorders. | 2012 | Details |
| A24096 | 23231303 | Med Phys | Measurement of blood flow and xenon solubility coefficient in the human liver by xenon-enhanced computed tomography. | 2012 | Details |
| A24097 | 23230902 | Liver Int | Increased risks of epilepsy and neuropsychiatric diseases in children of mothers with alcoholic liver disease. | 2012 | Details |
| A24101 | 23227839 | Biomark Med | Serum biomarkers in nonalcoholic steatohepatitis: value for assessing drug effects? | 2012 | Details |
| A24102 | 23227347 | Int J Hepatol | Posttransplant metabolic syndrome. | 2012 | Details |
| A24103 | 23227282 | Methodist Debakey Cardiovasc J | Fatty liver: a link to cardiovascular disease--its natural history, pathogenesis, and treatment. | 2013 | Details |
| A24104 | 23227248 | PLoS One | Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases. | 2012 | Details |
| A24105 | 23226761 | Exp Ther Med | Tesaglitazar ameliorates non-alcoholic fatty liver disease and atherosclerosis development in diabetic low-density lipoprotein receptor-deficient mice. | 2012 | Details |
| A24106 | 23226654 | Indian J Endocrinol Metab | Raised liver enzymes in newly diagnosed Type 2 diabetes are associated with weight and lipids, but not glycaemic control. | 2012 | Details |
| A24107 | 23226254 | PLoS One | Genetic variants in PNPLA3 and risk of non-alcoholic fatty liver disease in a Han Chinese population. | 2012 | Details |
| A24109 | 23223552 | JPEN J Parenter Enteral Nutr | A meal high in saturated fat evokes postprandial dyslipemia, hyperinsulinemia, and altered lipoprotein expression in obese children with and without nonalcoholic fatty liver disease. | 2012 | Details |
| A24110 | 23223517 | Drug Metab Dispos | Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease. | 2012 | Details |
| A24111 | 23221052 | Nihon Shokakibyo Gakkai Zasshi | [Clinical characteristics of non-alcoholic steatohepatitis (NASH) patients who progressed from F3 stage fibrosis to cirrhotic NASH]. | 2012 | Details |
| A24112 | 23220074 | Nutr Metab Cardiovasc Dis | Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children. | 2012 | Details |
| A24113 | 23218652 | Gastroenterol Hepatol | [Acute liver failure after bariatric surgery. A case report and literature review]. | 2012 | Details |
| A24114 | 23216963 | Hepatol Res | Evaluation of the Liver Fibrosis Index calculated by using real-time tissue elastography for the non-invasive assessment of liver fibrosis in chronic liver diseases. | 2012 | Details |
| A24115 | 23215811 | J Gastroenterol Hepatol | Apolipoprotein B/AI ratio is independently associated with non-alcoholic fatty liver disease in nondiabetic subjects. | 2013 | Details |
| A24116 | 23214350 | Acta Gastroenterol Latinoam | [Transient elastography: noninvasive assessment of liver fibrosis. Report of 1,000 cases in Argentina]. | 2012 | Details |
| A24117 | 23213074 | Hepatology | Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease. | 2013 | Details |
| A24118 | 23213066 | Hepatology | Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study. | 2013 | Details |
| A24120 | 23212097 | Lab Invest | Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome. | 2012 | Details |
| A24121 | 23211853 | Am J Gastroenterol | Non-alcoholic fatty liver disease and obesity: not all about body mass index. | 2012 | Details |
| A24122 | 23211317 | J Hepatol | Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease. | 2012 | Details |
| A24123 | 23209914 | Int J Hepatol | Focus on therapeutic strategies of nonalcoholic Fatty liver disease. | 2012 | Details |
| A24124 | 23207144 | J Hepatol | Leptin is key to peroxynitrite-mediated oxidative stress and Kupffer cell activation in experimental non-alcoholic steatohepatitis. | 2012 | Details |
| A24125 | 23206728 | Prog Lipid Res | Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis. | 2012 | Details |
| A24126 | 23205728 | Free Radic Res | Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with Vitamin E. | 2013 | Details |
| A24127 | 23203768 | Mol Nutr Food Res | Prebiotic approach alleviates hepatic steatosis: implication of fatty acid oxidative and cholesterol synthesis pathways. | 2012 | Details |